Therefore, together, these data demonstrate that loss of myeloid CD11c+ cells leads to an enhanced accumulation of differentiated tumor-specific T cells within the tumor bed by mechanisms that are independent of endogenous lymphocytes. The gene discussed is ITGAX; the disease is neoplasm.